| 產(chǎn)品名稱 | T56-LIMKi - T5601640 |
| 產(chǎn)品貨號 | Axon 2721 CAS [924473-59-6] MF C19H14F3N3O3MW 389.33 Purity: 99% Soluble in DMSO Description T56-LIMKi is an inhibitor of LIMK2. T56-LIMKi efficiently inhibited the growth of NF1-/- MEF, ST88-14, U87, and Panc-1 cells with IC50 values of 30 μM, 18 μM, 7 μM, and 35 μM, respectively. Moreover, T56-LIMKi reduced tumor size and p-cofilin levels in the Panc-1 tumors in vivo. Potential drug for pancreatic cancer, glioma and schwannoma cells. KEYWORDS: T56-LIMKi | supplier | LIMK2 inhibitor | T5601640 | T56 LIMKi | T56LIMKi | T 5601640 | T-5601640 | CAS [924473-59-6] | Non Selective (ADF-cofilin) | LIMK2 | Inhibitor | Enzymes | LIM | LIM kinase | cofilin | ADF | Panc-1 |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
T56-LIMKi - T5601640Axon 2721 CAS [924473-59-6] MF C19H14F3N3O3
DescriptionT56-LIMKi is an inhibitor of LIMK2. T56-LIMKi efficiently inhibited the growth of NF1-/- MEF, ST88-14, U87, and Panc-1 cells with IC50 values of 30 μM, 18 μM, 7 μM, and 35 μM, respectively. Moreover, T56-LIMKi reduced tumor size and p-cofilin levels in the Panc-1 tumors in vivo. Potential drug for pancreatic cancer, glioma and schwannoma cells. KEYWORDS: T56-LIMKi | supplier | LIMK2 inhibitor | T5601640 | T56 LIMKi | T56LIMKi | T 5601640 | T-5601640 | CAS [924473-59-6] | Non Selective (ADF-cofilin) | LIMK2 | Inhibitor | Enzymes | LIM | LIM kinase | cofilin | ADF | Panc-1
LIM Kinase 2 (LIMK2) inhibitor
Chemical name3-Methyl-N-(3-(3-(trifluoromethyl)phenylcarbamoyl)phenyl)isoxazole-5-carboxamide Parent CAS No.[924473-59-6] |
| 產(chǎn)品資料 |
